BRYAN MEDICAL, LLC: public contracts won without a rival in United States

Updated 17 October 2026 · 2024-04-04 to 2025-04-17 · all of United States · record in the register

BRYAN MEDICAL, LLC: public contracts won without a rival in United States: 2 uncontested awards; 67% of its awards; 0 without a competition; 2 single bid.

Assay record ASY-US-12RTF0H089 · Cite as: Assay Systems, “BRYAN MEDICAL, LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/bryan-medical-llc/

1
2uncontested awards
67%of its awards
0without a competition
2single bid

BRYAN MEDICAL, LLC won 2 of its 3 public contract awards in United States without a rival from 2024-04-04 to 2025-04-17, worth $39.4K: 0 without a competition and 2 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Department of Veterans Affairs with 2.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Department of Veterans Affairs2uncontested3awards$39.4Kvalue

Department of Veterans Affairs gave BRYAN MEDICAL, LLC 3 awards: 0 without a competition, 2 after a competition with a single bid. First 2024-04-04, latest 2025-04-17.

Latest awards without a rival

DateBuyerHowValueStated reason
2025-04-17Department of Veterans Affairs
36C26225N0639
Single bid
FULL AND OPEN COMPETITION
$13.6K—
2024-11-14Department of Veterans Affairs
36C24625N0279
Single bid
FULL AND OPEN COMPETITION
$25.9K—

Every uncontested award in United States · All countries · BRYAN MEDICAL, LLC in the register

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.